Janaiah Kota is the Executive Director of Molecular Therapeutics at Ultragenyx, specializing in AAV gene therapy and RNAi therapeutics. Educated at the Indian Agricultural Research Institute, he has built a career developing novel therapies for diseases, holding multiple patents and leading research programs at institutions like Indiana University School of Medicine. Colleagues describe him as a dedicated and expert researcher.
Fueled by a childhood passion for biology, Janaiah aims to apply his knowledge to improve human lives. This mission stems from his upbringing as the son of uneducated parents in rural India, driving him to bring commercially viable and safe treatments to patients as efficiently as possible.
He holds patents for innovative treatments for both pancreatic cancer and hepatic neoplasia.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.